A phase II open-label multicenter study of gefitinib in combination with irradiation followed by chemotherapy in patients with inoperable stage III non-small cell lung cancer

10.18632/oncotarget.12741 ◽

2016 ◽

Vol 8 (9) ◽

pp. 15924-15933 ◽

Author(s):

Antonin Levy ◽

Etienne Bardet ◽

Benjamin Lacas ◽

Jean-Pierre Pignon ◽

Julien Adam ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Multicenter Study ◽

Stage Iii ◽

Small Cell Lung ◽

Download Full-text

PD-154 An open-label, multi centre phase II, non-comparative trial of ZD1839 monotherapy in chemotherapy-naive patients with stage IV or stage III non-operable non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/s0169-5002(05)80487-8 ◽

2005 ◽

Vol 49 ◽

pp. S111-S112

Author(s):

M. Reck ◽

E. Buchholz ◽

C. Gahlemann ◽

U. Gatzemeier ◽

C. Manegold

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Stage Iv ◽

Comparative Trial ◽

Stage Iii ◽

Small Cell Lung ◽

Download Full-text

A phase II, open-label, multicenter study of the ALK inhibitor alectinib in an ALK+ non-small-cell lung cancer (NSCLC) U.S./Canadian population who had progressed on crizotinib (NP28761).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.8019 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 8019-8019 ◽

Author(s):

Leena Gandhi ◽

Alice Shaw ◽

Shirish M. Gadgeel ◽

Gregory Riely ◽

Jeremy Cetnar ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Multicenter Study ◽

Small Cell Lung ◽

Alk Inhibitor ◽

Canadian Population

Download Full-text

An open-label, multi centre, phase II, non-comparative trial of ZD1839 monotherapy in chemotherapy-naive patients with stage IV or stage III non-operable non-small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7098 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7098-7098 ◽

Author(s):

M. Reck ◽

U. Gatzemeier ◽

E. Bucholz ◽

C. G. Gahlemann ◽

C. Manegold

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Stage Iv ◽

Comparative Trial ◽

Stage Iii ◽

Small Cell Lung ◽

Download Full-text

P2-171: Phase II and pharmacokinetic (PK) study of induction docetaxel/cisplatin followed by pulsed docetaxel chemoradiation for stage III non-small cell lung cancer

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000283829.85288.5c ◽

2007 ◽

Vol 2 (8) ◽

pp. S637-S638

Author(s):

Yuhchyau Chen ◽

Kishan J. Pandya ◽

Therese Smudzin ◽

Raman Qazi ◽

Brian Smith ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Stage Iii ◽

Small Cell Lung

Download Full-text

865 Poster Interrupted phase II trial of adjuvant docetaxel and radiotherapy in resected stage III non-small cell lung cancer (NSCLC)

Radiotherapy and Oncology ◽

10.1016/s0167-8140(02)83174-7 ◽

2002 ◽

Vol 64 ◽

pp. S256-S257

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Stage Iii ◽

Small Cell Lung ◽

Download Full-text

HELPER study: A phase II trial of continuous infusion of endostar combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancer

Radiotherapy and Oncology ◽

10.1016/j.radonc.2018.10.032 ◽

2019 ◽

Vol 131 ◽

pp. 27-34 ◽

Author(s):

Yirui Zhai ◽

Honglian Ma ◽

Zhouguang Hui ◽

Lujun Zhao ◽

Dongming Li ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Continuous Infusion ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Stage Iii ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

Phase II trial of amonafide in patients with stage III and IV non-small-cell lung cancer

Lung Cancer ◽

10.1016/0169-5002(91)90430-e ◽

1991 ◽

Vol 7 (6) ◽

pp. 395

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Stage Iii ◽

Small Cell Lung

Download Full-text

Docetaxel plus cisplatin as neoadjuvant chemotherapy for unresectable stage III Non-Small-Cell Lung Cancer (NSCLC): A phase II study

Lung Cancer ◽

10.1016/s0169-5002(00)80374-8 ◽

2000 ◽

Vol 29 (1) ◽

pp. 113

Author(s):

M Dediu ◽

T Horvat ◽

A Tarlea ◽

A Nicodin ◽

M Movanu ◽

...

Keyword(s):

Lung Cancer ◽

Neoadjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Stage Iii ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

A phase 1b open-label, multicenter study of inhaled DV281, a TLR9 agonist, in combination with nivolumab in patients with advanced or metastatic non-small cell lung cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-21-0263 ◽

2021 ◽

pp. clincanres.0263.2021

Author(s):

Edward B. Garon ◽

Alexander I. Spira ◽

Melissa Johnson ◽

Lyudmila Bazhenova ◽

Joseph Leach ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Multicenter Study ◽

Small Cell Lung ◽

Tlr9 Agonist ◽

Download Full-text

Open-label multicenter randomized phase II study of docetaxel plus bevacizumab or pemetrexed plus bevacizumab for elderly (≥75 years old) patients (pts) with previously untreated advanced non-squamous non-small cell lung cancer (NSCLC): TORG1323

Annals of Oncology ◽

10.1093/annonc/mdy292.025 ◽

2018 ◽

Vol 29 ◽

pp. viii506

Author(s):

T. Honda ◽

T. Kouzuki ◽

Y. Tsunezuka ◽

N. Seki ◽

T. Shibayama ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Old Patients ◽

Randomized Phase Ii

Download Full-text